Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?

To: Hank who wrote (6227)	2/24/1999 9:59:00 AM
From: Linda Kaplan	Respond to of 7041

Yup. He's a mental "giant." LOL! Years ago I was involved with the founding of MacUwer magazine. The magazine with a small staff took on the large staffed monolith Macworld magazine published by Ziff Davis. The two publishers had had a long-standing war between them. MacUser was a success and Ziff Davis bought it out, for, the rumor was, $8 million, about 8x what it was worth. The hype is what makes the difference. This was a major triumph for the publisher of MacUser, who went back to England and bought another Rolls. I think he's still laughing. In that case, MacUser really was a good magazine, but worth nowhere near the price for which it was sold. Zonagen has been hyping Vasomax like crazy all along and now so is SGP. The drug isn't worth what they're suggesting and someday everyone will know that, just as it didn't take very long for zd to find out they'd been scammed. Linda